Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

You, Kyu Sic; Yi, Yong Weon; Cho, Jeonghee; Park, Jeong-Soo; Seong, Yeon-Sun

You, Kyu Sic; Yi, Yong Weon; Cho, Jeonghee; Park, Jeong-Soo; Seong, Yeon-Sun.

Afiliação

You KS; Department of Biochemistry, College of Medicine, Dankook University, Cheonan 31116, Chungcheongnam-do, Korea.
Yi YW; Graduate School of Convergence Medical Science, Dankook University, Cheonan 3116, Chungcheongnam-do, Korea.
Cho J; Department of Nanobiomedical Science, Dankook University, Cheonan 31116, Chungcheongnam-do, Korea.
Park JS; Department of Nanobiomedical Science, Dankook University, Cheonan 31116, Chungcheongnam-do, Korea.
Seong YS; Department of Biochemistry, College of Medicine, Dankook University, Cheonan 31116, Chungcheongnam-do, Korea.

Pharmaceuticals (Basel) ; 14(6)2021 Jun 18.

Article em En | MEDLINE | ID: mdl-34207383

Palavras-chave

EGFR inhibitor (EGFRi); EGFRi resistance; anti-EGFR therapy; anticancer; combination therapy; epidermal growth factor receptor (EGFR); triple-negative breast cancer (TNBC)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article